Secondary analysis of the GRADE trial (masked CGM in 1,080 participants with type 2 diabetes on metformin): sitagliptin and liraglutide had the highest time in range and least hypoglycaemia; glimepiride had the lowest time in range and most hypoglycaemia (P<0.001).
Secondary analysisn = 1,080
Bergenstal et al. Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial